19 Nov 2026, 08:33
Company UpdateMS
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Nov 2026, 08:33 | Follow-up assessments completed in Phase III AMPLIFY trial | Company Update | MS | 11001 | |
| 18 Nov 2026, 16:30 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 12 Nov 2026, 10:17 | First FDA Breakthrough Therapy designation in PSMA PET | Company Update | MS | 09014, 11001 | |
| 11 Nov 2026, 17:20 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 11 Nov 2026, 10:07 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 11 Nov 2026, 09:51 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 9 Nov 2026, 17:42 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 30 Oct 2026, 15:40 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 27 Oct 2026, 09:14 | Ph III CLARIFY trial target number of participants achieved | Company Update | MS | 11001 | |
| 23 Oct 2026, 10:39 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 20 Oct 2026, 19:40 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 13 Oct 2026, 09:30 | SAR-bisPSMA Presentation - Drug & Device Conference | Presentations | — | 03026 | |
| 8 Oct 2026, 10:00 | SECuRE update | Company Update | MS | 11001 | |
| 5 Oct 2026, 18:43 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 30 Sept 2026, 16:00 | CORPORATE GOVERNANCE STATEMENT | Company Administration | — | 03024 | |
| 30 Sept 2026, 15:52 | Appendix 4G | Company Administration | — | 03025 | |
| 30 Sept 2026, 15:45 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 24 Sept 2026, 18:45 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 22 Sept 2026, 16:55 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 21 Sept 2026, 09:51 | Date of Annual General Meeting 25 November 2026 | Meetings & Governance | — | 08006 | |
| 27 Aug 2026, 12:32 | Preliminary Final Report | Financial Results | MS | 03003, 03011, 03012, 03013, 03020 | |
| 25 Aug 2026, 08:03 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 12 Aug 2026, 19:18 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 7 Aug 2026, 16:52 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 6 Aug 2026, 17:58 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 6 Aug 2026, 09:57 | Bioshares Biotech Summit Presentation | Presentations | MS | 03026 | |
| 5 Aug 2026, 18:24 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 5 Aug 2026, 16:55 | Notification regarding unquoted securities - CU6 | Securities Administration | — | 06021 | |
| 5 Aug 2026, 10:00 | SECuRE update | Company Update | MS | 11001 | |
| 31 July 2026, 17:00 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 31 July 2026, 12:08 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 30 July 2026, 18:05 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 16 July 2026, 18:22 | Initial Director's Interest Notice - Rossiter | Director Interests | — | 02008 | |
| 16 July 2026, 09:32 | Allison Rossiter joins Clarity Board of Directors | Company Administration | — | 12001 | |
| 8 July 2026, 08:23 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 7 July 2026, 08:18 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 1 July 2026, 17:11 | Cleansing Notice | Securities Administration | — | 06018 | |
| 1 July 2026, 17:05 | Application for quotation of securities - CU6 | Securities Administration | — | 06020 | |
| 1 July 2026, 08:18 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 29 June 2026, 09:56 | Data on SAR-bisPSMA to be presented at EANM | Company Update | MS | 11001 | |
| 26 June 2026, 09:36 | Clarity celebrates 100-employee milestone | Company Administration | — | 12008 | |
| 25 June 2026, 17:17 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 22 June 2026, 17:12 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 18 June 2026, 17:21 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 June 2026, 17:56 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 27 May 2026, 16:41 | Notification regarding unquoted securities - CU6 | Securities Administration | — | 06021 | |
| 20 May 2026, 16:57 | Cleansing Notice | Securities Administration | — | 06018 | |
| 20 May 2026, 16:54 | Application for quotation of securities - CU6 | Securities Administration | — | 06020 | |
| 14 May 2026, 09:43 | Clarity receives $9.8 million R&D tax incentive refund | Periodic Reports | MS | 03014, 12008 | |
| 30 Apr 2026, 12:24 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 |